Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case
Hypertrophic cardiomyopathy (HCM) is a disease that is usually unresponsive to conservative pathogenetic therapy. It does not have clearly developed surgical correction algorithms. Heart transplantation (HTx) is the sole therapeutic option when drug therapy is ineffective and surgical reduction of h...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2022-07-01
|
| Series: | Вестник трансплантологии и искусственных органов |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/1483 |
| _version_ | 1826546275377479680 |
|---|---|
| author | M. R. Zaynetdinov M. N. Mukharyamov R. K. Dzhordzhikiya I. I. Vagizov M. A. Miroshnichenko I. V. Abdulyanov R. R. Khamzin D. I. Abdulganieva E. V. Dyakova A. Zh. Bayalieva N. F. Gizatullina N. Yu. Stekolshchikova M. M. Minnullin R. N. Khairullin |
| author_facet | M. R. Zaynetdinov M. N. Mukharyamov R. K. Dzhordzhikiya I. I. Vagizov M. A. Miroshnichenko I. V. Abdulyanov R. R. Khamzin D. I. Abdulganieva E. V. Dyakova A. Zh. Bayalieva N. F. Gizatullina N. Yu. Stekolshchikova M. M. Minnullin R. N. Khairullin |
| author_sort | M. R. Zaynetdinov |
| collection | DOAJ |
| description | Hypertrophic cardiomyopathy (HCM) is a disease that is usually unresponsive to conservative pathogenetic therapy. It does not have clearly developed surgical correction algorithms. Heart transplantation (HTx) is the sole therapeutic option when drug therapy is ineffective and surgical reduction of hypertrophic myocardium is not feasible. There are only sporadic reports in the literature about HTx for HCM. The novel coronavirus disease 2019 (COVID-19) pandemic has significantly affected the work of cardiac surgical units and, in particular, organ transplantation activities. This paper presents a clinical case of an HCM patient who underwent HTx, complicated by COVID-19 infection in the early postoperative period. |
| first_indexed | 2024-04-10T00:50:28Z |
| format | Article |
| id | doaj.art-1af5934955994657a4ff0cd45ee39830 |
| institution | Directory Open Access Journal |
| issn | 1995-1191 |
| language | Russian |
| last_indexed | 2025-03-14T05:31:10Z |
| publishDate | 2022-07-01 |
| publisher | Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov |
| record_format | Article |
| series | Вестник трансплантологии и искусственных органов |
| spelling | doaj.art-1af5934955994657a4ff0cd45ee398302025-03-05T14:11:53ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovВестник трансплантологии и искусственных органов1995-11912022-07-01242586410.15825/1995-1191-2022-2-58-641108Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical caseM. R. Zaynetdinov0M. N. Mukharyamov1R. K. Dzhordzhikiya2I. I. Vagizov3M. A. Miroshnichenko4I. V. Abdulyanov5R. R. Khamzin6D. I. Abdulganieva7E. V. Dyakova8A. Zh. Bayalieva9N. F. Gizatullina10N. Yu. Stekolshchikova11M. M. Minnullin12R. N. Khairullin13Kazan State Medical UniversityKazan State Medical University; Interregional Clinical Diagnostic CenterKazan State Medical University; Interregional Clinical Diagnostic CenterInterregional Clinical Diagnostic CenterInterregional Clinical Diagnostic CenterInterregional Clinical Diagnostic CenterInterregional Clinical Diagnostic CenterKazan State Medical University; Republican Clinical HospitalRepublican Clinical HospitalKazan State Medical UniversityKazan State Medical University; Interregional Clinical Diagnostic CenterInterregional Clinical Diagnostic CenterRepublican Clinical HospitalInterregional Clinical Diagnostic CenterHypertrophic cardiomyopathy (HCM) is a disease that is usually unresponsive to conservative pathogenetic therapy. It does not have clearly developed surgical correction algorithms. Heart transplantation (HTx) is the sole therapeutic option when drug therapy is ineffective and surgical reduction of hypertrophic myocardium is not feasible. There are only sporadic reports in the literature about HTx for HCM. The novel coronavirus disease 2019 (COVID-19) pandemic has significantly affected the work of cardiac surgical units and, in particular, organ transplantation activities. This paper presents a clinical case of an HCM patient who underwent HTx, complicated by COVID-19 infection in the early postoperative period.https://journal.transpl.ru/vtio/article/view/1483hypertrophic cardiomyopathyheart transplantationcovid19 |
| spellingShingle | M. R. Zaynetdinov M. N. Mukharyamov R. K. Dzhordzhikiya I. I. Vagizov M. A. Miroshnichenko I. V. Abdulyanov R. R. Khamzin D. I. Abdulganieva E. V. Dyakova A. Zh. Bayalieva N. F. Gizatullina N. Yu. Stekolshchikova M. M. Minnullin R. N. Khairullin Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case Вестник трансплантологии и искусственных органов hypertrophic cardiomyopathy heart transplantation covid19 |
| title | Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case |
| title_full | Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case |
| title_fullStr | Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case |
| title_full_unstemmed | Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case |
| title_short | Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case |
| title_sort | heart transplantation and covid 19 in the early postoperative period in hypertrophic cardiomyopathy a clinical case |
| topic | hypertrophic cardiomyopathy heart transplantation covid19 |
| url | https://journal.transpl.ru/vtio/article/view/1483 |
| work_keys_str_mv | AT mrzaynetdinov hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT mnmukharyamov hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT rkdzhordzhikiya hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT iivagizov hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT mamiroshnichenko hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT ivabdulyanov hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT rrkhamzin hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT diabdulganieva hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT evdyakova hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT azhbayalieva hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT nfgizatullina hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT nyustekolshchikova hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT mmminnullin hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase AT rnkhairullin hearttransplantationandcovid19intheearlypostoperativeperiodinhypertrophiccardiomyopathyaclinicalcase |